Finder makes money from featured partners, but editorial opinions are our own. Advertiser Disclosure
Biocardia Inc is a biotechnology business based in the US. Biocardia Inc shares (BCDA) are listed on the NASDAQ and all prices are listed in US Dollars. Biocardia Inc employs 28 staff and has a trailing 12-month revenue of around $1.9 million.
Our top pick for
Beginners
Our top pick for
Free trades
Our top pick for
Social traders
| Latest market close | $1.94 |
|---|---|
| 52-week range | $1.10 - $3.49 |
| 50-day moving average | $1.73 |
| 200-day moving average | $1.78 |
| Wall St. target price | $8.50 |
| PE ratio | N/A |
| Dividend yield | $0 (0%) |
| Earnings per share (TTM) | $-0.76 |
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Historical closes compared with the close of $1.94 from 2022-09-30
| 1 week (2022-09-23) | 4.30% |
|---|---|
| 1 month (2022-09-02) | 2.11% |
| 3 months (2022-07-01) | 32.88% |
| 6 months (2022-03-29) | N/A |
| 1 year (2021-10-01) | -35.12% |
|---|---|
| 2 years (2020-10-02) | -16.02% |
| 3 years (2019-10-02) | 3.55 |
| 5 years (2017-09-29) | 317.20% |
| Revenue TTM | $1.9 million |
|---|---|
| Gross profit TTM | $-7,543,000 |
| Return on assets TTM | -47.61% |
| Return on equity TTM | -107.01% |
| Profit margin | 0% |
| Book value | $0.38 |
| Market capitalisation | $33 million |
TTM: trailing 12 months
We're not expecting Biocardia Inc to pay a dividend over the next 12 months.
Biocardia Inc's shares were split on a 1:9 basis on 6 June 2019. So if you had owned 9 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Biocardia Inc shares – just the quantity. However, indirectly, the new 800% higher share price could have impacted the market appetite for Biocardia Inc shares which in turn could have impacted Biocardia Inc's share price.
Over the last 12 months, Biocardia Inc's shares have ranged in value from as little as $1.1 up to $3.49. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Biocardia Inc's is 1.2273. This would suggest that Biocardia Inc's shares are a little bit more volatile than the average for this exchange and represent, relatively-speaking, a slightly higher risk (but potentially also market-beating returns).
BioCardia, Inc. , a clinical-stage regenerative medicine company, develops cellular and cell-derived therapeutics for cardiovascular and pulmonary diseases. Its lead therapeutic candidate is the CardiAMP Cell Therapy System for the treatment of heart failure and chronic myocardial ischemia; and allogeneic cell therapy for cardiac and pulmonary disease. The company is also developing allogeneic cells therapeutic platform, an investigational culture expanded bone marrow derived mesenchymal cell therapy, which is in Phase I/II trial for the treatment of ischemic systolic heart failure. In addition, it offers the Helix biotherapeutic delivery system that delivers therapeutics into the heart muscle with a penetrating helical needle from within the heart; and Morph deflectable guides and sheaths. The company is based in Sunnyvale, California. .
Looking for a discount broker like Webull that offers something different? Here are some of the top alternatives to consider.
Here are the best renewable energy stocks that should be on your radar to help you grow your green portfolio
Here are 6 manganese stocks that should be on your radar as EV batteries create new demand.
Our list of 10 dividend stocks to watch in 2022.
Everything we know about the YanGuFang International Group IPO, plus information on how to buy in.
Looking to invest in tech? Here’s how to buy shares in the major tech companies, known as FAANG stocks.
A simple guide to buying stocks in your favorite European soccer team.
Steps to owning and managing JUVE, with 24-hour and historical pricing before you buy.
Steps to owning and managing ASR, with 24-hour and historical pricing before you buy.
Steps to owning and managing BVB, with 24-hour and historical pricing before you buy.